Study of 11 Autism Mouse Models Finds Shared Developmental Delays, Stronger Female Effects
Updated
Updated · Nature.com · Jun 17
Study of 11 Autism Mouse Models Finds Shared Developmental Delays, Stronger Female Effects
3 articles · Updated · Nature.com · Jun 17
Summary
Researchers profiled 251 samples from 11 monogenic autism mouse models and found genetically diverse mutations converged on disrupted radial glial development rather than wholly distinct pathways.
At embryonic stages, mutant mice showed a transient delay in radial glial lineage progression that largely resolved after birth, while the biggest shared transcriptional changes appeared at postnatal day 4 in neurons.
Those early postnatal neuronal changes broadly downregulated synaptic and ion-channel genes, and patch-clamp tests in four models linked larger transcriptomic shifts to bigger changes in excitability and synaptic signaling.
By postnatal day 14, convergence across models weakened, suggesting common early-stage mechanisms give way to more genotype-specific programs as development proceeds.
Sex-split analyses showed several models had larger gene-expression effects in females than males, adding to evidence that autism-linked mutations can act differently by developmental stage and sex.
If key brain disruptions in autism are only temporary, can new therapies intervene before the effects become permanent?
With AI now able to screen toddlers for autism from videos, how will this technology transform early intervention?
Breakthrough Organoid Research Uncovers Common Early Brain Disruptions in Autism Spectrum Disorder
Overview
A landmark study published in Nature by UCLA and Stanford researchers marks a major breakthrough in autism research. The team discovered that eight different autism-linked genetic mutations, despite coming from diverse genetic backgrounds, all converge on shared disruptions in early fetal brain development. This challenges the old idea that autism is just a collection of separate disorders and instead points to a common pathway of brain disruption. Using patient-derived brain organoids, the researchers showed that these shared disruptions could become targets for future therapies, opening new possibilities for understanding and treating Autism Spectrum Disorder.